Podcast
In the latest episode of 'On the frontlines', the real estate giant's ESG head tells the EB Podcast that while there has been no pushback on climate action by corporate India, questions remain over whether the booming real estate sector is decarbonising fast enough.
The ESG head of the Philippine power company arm tells the EB Podcast that sustainability needs to be communicated not as a “progressive idea” but a business strategy that benefits the bottom line.
In the second episode of 'On the frontlines', power firm CLP's group sustainability director Rosenthal talks to the EB Podcast about the challenges of steering sustainability in a carbon-heavy industry, closing coal plants and the need for pragmatism.
The sea-level rise expert has moved to Hong Kong – now seen as a gateway to more collaboration with China on climate science. But he tells the EB Podcast that data from US agencies is still critical for calculating climate defences in Asia.
全部Podcast
17 四月 2025
8 四月 2025
19 三月 2025
18 二月 2025
14 十一月 2024
7 十一月 2024
23 九月 2024
12 八月 2024
最多人阅读
-
![Malaysia's plantation and commodities minister Johari Abdul Ghan at SWR 2025]()
Malaysia’s commodities minister is touting palm oil biomass as a coal alternative, while signalling a hard stance on … -
![Cirata floating solar Indonesia]()
新闻 / 政策和金融
China is Southeast Asia’s biggest public funder of clean energy with US$2.7bn in investments: study
Indonesia received the most funding from China over the last decade, according to a new report. But uncertainties … -
![Indus_River_India_Pakistan_Treaty]()
India unilaterally suspended the 1960 Indus Water Treaty with Pakistan, citing cross-border terrorism amid longstanding calls for updates … -
![Transmission line Asean]()
The bulk of funding will be used to address intermittency and variability of renewables in off-grid areas, says … -
![Solar_Farn_Technician_Thailand]()
Entrenched gas interests and domestic issues put a strain on Thailand’s solar potential. -
![Healthcare_Worker_Pandemic_Jakarta]()
Antimicrobial resistance (AMR) could cost Asia up to US$700 billion by 2050 and surpass cancer as the world’s …
